PATRICIA ANN BASFORD,ANTHONY MICHAEL CAMPETA,ADAM GILLMORE,MATTHEW CAMERON JONES,ELEFTHERIOS KOUGOULOS,SUMAN LUTHRA,ROBERT WALTON
申请号:
PT16183844
公开号:
PT3150610T
申请日:
2011.02.10
申请国别(地区):
PT
年份:
2019
代理人:
摘要:
The present invention relates to novel polymorphic forms of 8-fluoro-2-{4-[(methylamino)methyl]phenyf}-1,3,4,5-tetrahydro-6H-azepino(5,4,3-cd]indol-6-one;(I), and to processes for their preparation. Such polymorphic forms may be a component of a pharmaceutical composition and may be used to treat a mammalian disease condition mediated by poly(ADP-ribose) polymerase activity including the disease condition such as cancer.